AlphaFold predicted structure
GRM7 · Q14831

Mean pLDDT
84.4/ 100
Confident
915 residues
Confidence breakdown
- Very high(≥ 90)55%
- Confident(70–90)31%
- Low(50–70)8%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glutamate metabotropic receptor 7
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalSevere microcephaly
BIALLELIC, autosomal or pseudoautosomalneurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
Global developmental delay
neurodevelopmental disorder
early-infantile DEE
autosomal recessive non-syndromic intellectual disability
Brain atrophy
Seizure
Hypotonia
microcephaly
Bilateral multifocal epileptiform discharges
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Metabotropic glutamate receptor 7
G protein-coupled receptor activated by glutamate that regulates axon outgrowth through the MAPK-cAMP-PKA signaling pathway during neuronal development (PubMed:33500274). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase that it inhibits (PubMed:9473604)
GRM7 · Q14831

Mean pLDDT
84.4/ 100
Confident
915 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0